---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-013398"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2022-04-06T23:59:59+00:00"
generated_at: "2026-06-26T09:07:19.598483+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# First Wave BioPharma CMO James Pennington to retire, will consult until successor named

## Summary
- James Pennington, M.D., Chief Medical Officer, informed company of retirement on March 31, 2022.
- No disagreement with operations, policies, or practices was cited in the notice.
- Pennington will transition to a consultant role until a new CMO is appointed.
- Successor has not yet been announced.

## SEC filing metadata
- accession: 0001140361-22-013398
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2022-04-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000114036122013398/0001140361-22-013398-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000114036122013398/brhc10036192_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-013398
- JSON: https://secwatch.observer/filing/0001140361-22-013398.json
- Plain text: https://secwatch.observer/filing/0001140361-22-013398.txt

## Key facts
- Executive change
  James Pennington, M.D. retired as Chief Medical Officer at GridAI Technologies Corp..
  - Action: retired
  - Role: Chief Medical Officer
  source text: On March 31, 2022, James Pennington, M.D., Chief Medical Officer of First Wave BioPharma, Inc. (the “Company”), informed the Company of his intention to retire as Chief Medical Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1604191/000114036122013398/0001140361-22-013398-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.